Cervical cancer remains a significant public health issue, particularly in regions with low screening and vaccination rates. A study calculated age-standardized incidence rates for cervical cancer in the US-Affiliated Pacific Islands (USAPI) and found that these rates were notably higher than those in the mainland US, highlighting the urgent need for targeted prevention strategies in these areas (ref: Gopalani doi.org/10.1001/jamaoncol.2024.3675/). In North Texas, disparities in HPV vaccination rates were observed, with initiation estimates ranging from 6.3% to 69.1% among children and teenagers. This region also reported higher incidence rates of HPV-related cancers, suggesting a direct correlation between low vaccination rates and increased cancer incidence (ref: Adekanmbi doi.org/10.1001/jamanetworkopen.2024.31807/). Furthermore, a study in Tripura, India, demonstrated that the prevalence of HPV increased with cervical cytological abnormalities, indicating a pressing need for effective screening and vaccination programs to mitigate the risk of cervical cancer (ref: Bhattacharya doi.org/10.1093/aje/). The vulnerability of females with Autism Spectrum Disorder (ASD) to cervical cancer due to low HPV vaccination and screening uptake was also emphasized, underscoring the necessity for tailored public health interventions (ref: Chen doi.org/10.1007/s10803-024-06565-2/). Additionally, the psychometric evaluation of the Persian version of the Quality of Life Questionnaire for Women Infected with HPV highlighted the importance of addressing the psychosocial aspects of HPV infection and its impact on quality of life (ref: Arashlouei doi.org/10.1186/s12889-024-19954-0/).